Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhTPO for Sepsis-Associated Severe Thrombocytopenia
NCT02707497Phase 3Recruiting
- Start
- Apr 2019
- Primary completion
- Aug 2024
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant human thrombopoietin in Thrombocytopenia. Started Apr 2019; status: recruiting.
02
Drugs
recombinant human thrombopoietin
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT02707497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02707497.